Spruce Biosciences

PriceSpruce Biosciences

SPRB

Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The pipeline products of the company include Tralesinidase Alfa (TA-ERT), and Tildacerfont/ Cortibon, a Companion Diagnostic, developed in partnership with HMNC Brain Health.

Historical stock price chart and annual return over the past years

-95%

5 years

% Total

SPRB
-45%

5 years

Annual Return

SPRB